COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 in Wuhan city, Hubei province, China. This is the third and largest coronavirus outbreak since the new millennium after SARS in 2002 and Middle East respiratory syndrome (MERS) in 2012. Over 3 million people ha...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Ophthalmol
Главные авторы: Thng, Zheng Xian, De Smet, Marc D, Lee, Cecilia S, Gupta, Vishali, Smith, Justine R, McCluskey, Peter J, Thorne, Jennifer E, Kempen, John H, Zierhut, Manfred, Nguyen, Quan Dong, Pavesio, Carlos, Agrawal, Rupesh
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316101/
https://ncbi.nlm.nih.gov/pubmed/32532764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316586
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы